Menarini Silicon Biosystems announce launch of new CELLSEARCH CTC test with DLL3 biomarker for small cell lung cancer
Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, have announced the availability of its new CELLSEARCH CTC lab service to detect expression of the Delta-Like Ligand 3 (DLL3) protein in tumour cells circulating in the bloodstream. This biomarker is mainly expressed in difficult-to-treat cancers. The new MSB lab service opens the door to the development of further minimally invasive tests that leverage the prognostic and predictive value of biomarkers in medical settings with high unmet needs.